We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 82

Omnibus claims: Back to business as usual
  • Minter Ellison
  • Australia
  • July 19 2016

The Full Federal Court has recently handed down its decision in the appeal by GlaxoSmithKline (GSK) against the earlier finding by Justice Rares


"Just DAST it" - Gilead succeeds on insufficiency and inutility for Hepatitis C treatment
  • Minter Ellison
  • Australia
  • March 29 2016

Gilead commenced proceedings against Idenix seeking revocation of Idenix's Australian patent No 2003247084 (Patent). The Patent was filed on 27 June


Agreed or liquidated damages that are neither extravagant nor unconscionable are not penal and therefore are recoverable
  • Minter Ellison
  • Australia
  • September 4 2015

Agreed damages were found not to be extravagant or unconscionable, therefore not a penalty. Facts On 3 October 2007, IPN Medical Centres Pty Ltd


Health & Ageing sector - increasing investment opportunities
  • Minter Ellison
  • Australia, China
  • February 26 2016

Increased deal activity is likely in Australia's health and aged care sector in 2016, driven by: investment interest from China Australian players


Parameteritis pokes holes in Swiss-type claim
  • Minter Ellison
  • Australia
  • December 2 2016

The Full Federal Court has recently handed down its decision in the appeal by Otsuka Pharmaceutical Co (Otsuka) against the earlier finding by


The new exclusive club of patent enforcement
  • Minter Ellison
  • Australia
  • November 8 2016

In a relatively recent flurry of decisions, the Federal Court examined a variety of agreements purporting to give exclusive rights to various


Productivity Commission releases Draft Report into Intellectual Property Arrangements - Part 1: Overview and PatentsPharmaceuticals
  • Minter Ellison
  • Australia
  • April 29 2011

Today, the Productivity Commission released its draft report into Australia's intellectual property regime. The report is wide-ranging, covering


High Court confirms proper approach to assessing inventive step
  • Minter Ellison
  • Australia
  • September 9 2015

The High Court in Australia last week handed down its decision in the patent dispute regarding blockbuster cholesterol drug rosuvastatin (sold by


Update: Proportional costs orders made in Gilead v Idenix proceedings
  • Minter Ellison
  • Australia
  • September 4 2015

Update: Proportional costs orders made in Gilead v Idenix proceedings As reported in our earlier post, Gilead recently succeeded in invalidating key


2015 Patent recap: The 8 (patent) days of Christmas
  • Minter Ellison
  • Australia
  • December 9 2015

The High Court of Australia rarely considers patent cases, handing down only two decisions in the past seven years. This year, however, we saw two